Trial Details

TERMINATED
Basic Information
Clinical ID c725
Identifier NCT06153420
Trial Title Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome With Diarrhea
Interventions DRUG: CIN-103|DRUG: Placebo
Participant Information
Sponsor CinPhloro Pharma, LLC
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2023-12-28
Primary Completion Date 2025-07-28
Completion Date 2025-07-28